<DOC>
	<DOCNO>NCT01754805</DOCNO>
	<brief_summary>A drug interaction study evaluate effect ASP015K ( twice daily ) pharmacokinetics ( PK ) weekly oral methotrexate ( MTX ) .</brief_summary>
	<brief_title>A Drug Interaction Study Evaluate Pharmacokinetics ASP015K Methotrexate Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description>Patients check day -1 remain confined exit procedure perform morning day 10 . Patients return 1 post-treatment follow-up visit day 13 . Patients receive single dose methotrexate day 1 day 8 ASP015K ( twice daily ) day 3 8 plus morning day 9 .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>1 . If female , subject must least 2 year post menopausal surgically sterile per documentation provide medical professional subject pregnant document negative serum pregnancy test Screening negative urine pregnancy test checkin 2 . If male , subject must agree sexual abstinence and/or use highly effective method birth control study period 60 day last dose study drug 3 . Subject must clinical diagnosis Rheumatoid Arthritis ( RA ) least 6 month prior Screening 4 . Subject must stable 15 25 mg dose methotrexate &gt; 28 day prior Screening 5 . If subject nonbiologic disease modify antirheumatic drug ( DMARDs ) therapy , dose must stable &gt; 28 day prior Screening 6 . Subject must willing able comply study requirement 1 . Subject previous history clinically significant neurological , gastrointestinal , renal , hepatic , pulmonary , metabolic , cardiovascular , psychiatric , endocrine , hematological disorder disease , medical condition would preclude participation study 2 . Subject known history positive test hepatitis B surface antigen ( HbsAg ) hepatitis C antibody history positive test human immunodeficiency virus ( HIV ) infection 3 . Subject receive live virus vaccination within last 30 day prior study drug administration 4 . Subject Body Mass Index ( BMI ) &gt; 35 ( kg/m2 ) 5 . Subject biologic disease modify antirheumatic drug ( DMARDs ) therapy 6 . Subject current history anemia define hemoglobin less 12 g/dL 7 . Subject recent history ( within last 6 month ) drug alcohol abuse positive urine screen alcohol drug abuse/illegal drug Screening checkin 8 . Subject receive investigational agent within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>ASP015K</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>